Inventor
SANDERS MARTIN E
US56 patents
⚠️ This page may combine multiple inventors who share the name “SANDERS MARTIN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IO THERAPEUTICS INC
46 patentsUS10471030B2Nov 12, 2019
Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC14 citations94
US10231944B2Mar 19, 2019
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC14 citations94
US10213401B2Feb 26, 2019
Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC18 citations94
US10004708B2Jun 26, 2018
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC18 citations94
US10004709B2Jun 26, 2018
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC18 citations94
US9907768B2Mar 6, 2018
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC25 citations94
US11065219B2Jul 20, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC7 citations93
US10980759B2Apr 20, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC7 citations93
US10973791B2Apr 13, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC7 citations93
US10857117B2Dec 8, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC7 citations93
US10806713B2Oct 20, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC7 citations93
US10485775B2Nov 26, 2019
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC11 citations93
US10835507B2Nov 17, 2020
Treatment of muscular disorders with combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC12 citations86
US10881628B2Jan 5, 2021
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC3 citations84
US10874628B2Dec 29, 2020
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC4 citations84
US10874627B2Dec 29, 2020
Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC6 citations84
US10532074B2Jan 14, 2020
RAR selective agonists in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC9 citations84
US10517843B2Dec 31, 2019
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC7 citations84
US10363272B2Jul 30, 2019
RAR selective agonists in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC10 citations84
US10123982B2Nov 13, 2018
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC10 citations84
US10092535B2Oct 9, 2018
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC4 citations84
US9877941B2Jan 30, 2018
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC3 citations84
US10966950B2Apr 6, 2021
Use of an RXR agonist in treating HER2+ cancers
IO THERAPEUTICS INC11 citations83
US11786555B2Oct 17, 2023
RAR selective agonists in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC1 citations73
US11779558B2Oct 10, 2023
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC1 citations73
US11737996B2Aug 29, 2023
Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC1 citations73
US10987330B2Apr 27, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC1 citations73
US10980760B2Apr 20, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations73
US10980761B2Apr 20, 2021
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations73
US10874694B2Dec 29, 2020
RAR selective agonists in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC2 citations73
US10532073B2Jan 14, 2020
RAR selective agonists in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC3 citations73
US10485778B2Nov 26, 2019
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC1 citations73
US12115193B2Oct 15, 2024
Methods of using RARγ agonists for cancer treatment
IO THERAPEUTICS INC0 citations63
US11793835B2Oct 24, 2023
Methods of using RARγ agonists for cancer treatment
IO THERAPEUTICS INC1 citations63
US11690831B2Jul 4, 2023
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US11690832B2Jul 4, 2023
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US11648223B2May 16, 2023
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
IO THERAPEUTICS INC0 citations63
US11517549B2Dec 6, 2022
Treatment of disease with esters of selective RXR agonists
IO THERAPEUTICS INC0 citations63
US10946001B2Mar 16, 2021
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US10842764B2Nov 24, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US10702489B2Jul 7, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US10695312B2Jun 30, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US10588881B2Mar 17, 2020
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US10278932B2May 7, 2019
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
IO THERAPEUTICS INC0 citations63
US12383521B2Aug 12, 2025
Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists
IO THERAPEUTICS INC0 citations62
US11224583B2Jan 18, 2022
Use of an RXR agonist in treating HER2+ cancers
IO THERAPEUTICS INC0 citations60
US HEALTH
2 patentsIGM BIOSCIENCES INC
1 patentUNIV LELAND STANFORD JUNIOR
1 patentShowing the top 50 of 56 patents by PatentIndex Score.